Insight on hepatitis B curative drug development with Dr. Mike Sofia

On this episode B Heppy we sit down with Dr. Mike Sofia, Co-founder and Chief Scientific Officer at Arbutus Biopharma to talk about his company's work on hepatitis B curative therapies. Listen and learn more about the pre-clinical process.  Resources:Arbutus BiopharmaDrug Watch Clinical Trial Finder Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook